Amcasertib 5 mg | Purity Not Available
TargetMol

Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.
More Information Supplier PageAmcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.
More Information Supplier PageRelebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageRelebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageRelebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageQS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier PageQS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier Page